Entering text into the input field will update the search result below

Amicus' Galafold OK'd in Canada; shares up 2% after hours

Sep. 14, 2017 4:23 PM ETAmicus Therapeutics, Inc. (FOLD) StockBy: Douglas W. House, SA News Editor3 Comments
  • Amicus Therapeutics (NASDAQ:FOLD) is up 2% after hours on average volume in response to its announcement that Health Canada has approved Galafold (migalastat) for the treatment of Fabry disease.
  • The company says the product will be available to patients in the coming weeks.

Recommended For You

About FOLD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
FOLD--
Amicus Therapeutics, Inc.